# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-18-003719
Filing Date
2018-05-09
Accepted
2018-05-09 14:10:57
Documents
49
Period of Report
2018-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | f10q_050918p.htm | 10-Q | 589616
2 | EXHIBIT 10.1 | exh_101.htm | EX-10.1 | 2087
3 | EXHIBIT 31.1 | exh_311.htm | EX-31.1 | 11240
4 | EXHIBIT 31.2 | exh_312.htm | EX-31.2 | 11594
5 | EXHIBIT 32.1 | exh_321.htm | EX-32.1 | 4300
6 | EXHIBIT 32.2 | exh_322.htm | EX-32.2 | 4253
13 | GRAPHIC | exh101_1.jpg | GRAPHIC | 239747
14 | GRAPHIC | exh101_2.jpg | GRAPHIC | 211996
15 | GRAPHIC | exh101_3.jpg | GRAPHIC | 140970
| Complete submission text file | 0001171843-18-003719.txt |  | 4905287

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL INSTANCE FILE | bcrx-20180331.xml | EX-101.INS | 775202
8 | XBRL SCHEMA FILE | bcrx-20180331.xsd | EX-101.SCH | 48597
9 | XBRL CALCULATION FILE | bcrx-20180331_cal.xml | EX-101.CAL | 34667
10 | XBRL DEFINITION FILE | bcrx-20180331_def.xml | EX-101.DEF | 342692
11 | XBRL LABEL FILE | bcrx-20180331_lab.xml | EX-101.LAB | 327072
12 | XBRL PRESENTATION FILE | bcrx-20180331_pre.xml | EX-101.PRE | 349951

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 18817727
SIC: 2836 Biological Products, (No Diagnostic Substances)